Navigation Links
MiMedx Announces Record First Quarter 2013 Results
Date:5/1/2013

KENNESAW, Ga., May 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NasdaqCM: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended March 31, 2013.

Highlights of First Quarter 2013 Results include:

  • Revenue exceeded forecast for fifth consecutive quarter
  • Revenue more than triples over first quarter of 2012
  • Fifth consecutive quarter of positive Adjusted EBITDA
  • Gross Margins improved by 10 percent over Q1 of prior year
  • Company reiterates 2013 guidance
  • First Quarter 2013 ResultsThe Company recorded record revenue for the quarter ended March 31, 2013, with revenue of $11.6 million, a three-fold increase over first quarter of 2012 revenue of $3.7 million. The Company's first quarter gross margins were 84% as compared to 74% in the first quarter of last year. Earnings before interest, taxes, depreciation, amortization and share based compensation (Adjusted EBITDA*) for the first quarter of 2013 were $1.1 million, a $805,000 or 256% improvement, as compared to the Adjusted EBITDA of $314,000 for the first quarter of 2012. The Net loss for the quarter was $1.6 million which included a one-time charge of $1.3 million for debt discount related to the conversion of our senior secured promissory notes.

    Management Commentary on First Quarter ResultsParker H. "Pete" Petit, Chairman and CEO, stated, "We are pleased that our revenue performance exceeded the $11.5 million upper range of our guidance. We increased revenue three fold over the prior year first quarter and continued to produce strong gross profit margins, equaling our fourth quarter of 2012 record gross margins of 84%. We are pleased to report our fifth consecutive quarter of positive Adjusted EBITDA, however, we continue to balance the investments in our sales org
    '/>"/>

    SOURCE MiMedx Group, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
    2. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
    3. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
    4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
    5. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
    6. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
    7. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
    8. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
    9. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
    10. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
    11. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... July 10, 2014 Research and Markets ... the "International Photonic Integrated Circuit (Monolithic Integration, ... 2019" report to their offering. ... concept of photonic integration traces its roots in ... promise of photonic integration went unexplored and unfulfilled ...
    (Date:7/10/2014)... April 15, 2014 -- According to the International ... nuclear security comes from terrorists acquiring sufficient quantities ... construct a crude nuclear explosive device. The IAEA ... trafficking have involved gram-level quantities, which can be ... According to a new study appearing this week ...
    (Date:7/10/2014)... June 17, 2014 Using microscopic polymer light ... gases, researchers at MIT,s Quantum Photonics Laboratory have ... in the parts-per-billion range. Optical sensors are ideal ... high signal-to-noise ratio, compact, lightweight nature, and immunity ... sensors had been developed before, the MIT team ...
    (Date:7/10/2014)... psychiatric disorders has been extremely challenging because there are ... insufficient to cause disease. Now investigators reporting in the ... Cell Stem Cell describe a strategy that may ... other risk factors or environmental exposures to affect the ... genetic variant that may predispose individuals to schizophrenia. ...
    Breaking Biology Technology:International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Sensitive detection method may help impede illicit nuclear trafficking 2Swell new sensors 2New strategy could uncover genes at the root of psychiatric illnesses 2
    ... 11 Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ... results for the fourth quarter of 2008 on Tuesday, ... conjunction with the issuance of the press release, Idenix ... ET on Tuesday, February 17, 2009 to discuss the ...
    ... XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: ... Shweiger have been appointed to XTL,s Board of,Directors, effective ... assuming,the role of Co-Chief Executive Officer, with no remuneration, ... Ron Bentsur, Co-Chief Executive Officer ...
    ... Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today ... and treatment of a physiological disorder that most likely ... seizure. , Victhom has recently filed a patent application ... sudden unexpected death in epilepsy (SUDEP) using its neuromodulation ...
    Cached Biology Technology:XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 3Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP) 2Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP) 3
    (Date:7/10/2014)... , June 27, 2014  Pomerantz LLP has ... Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain ... United States District Court, Middle District of ... behalf of a class consisting of all persons ... securities between December 17, 2013 and May 22, ...
    (Date:7/10/2014)... Conn. , July 2, 2014 NXT-ID, Inc., (OTCQB: ... reports that CEO Mr. Gino Pereira was interviewed ... show in Tampa Florida . Mr. Pereira ... host Cedric Harris and how the Wocket™ aims ... alternative.  Cedric Harris tells Gino ...
    (Date:7/10/2014)... Fingerprint Cards, (FPC,s) new ... (DW). An Asian OEM has selected FPC1021 for a flagship ... August 2014.   FPC is proud to announce ... planned date for start of mass production in August 2014. ... 5M, for delivery in the first half of July. The ...
    Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
    ... a looming water crisis, driven by climate change, growing ... of this issue, the National Science Foundation has selected ... Engineering Research Center (ERC) to address this challenge by ... initial grant is $18.5 million spread over five years, ...
    ... Scientists at the U.S. Department of Energy,s (DOE) Brookhaven ... the metabolic processes in rapeseed plants - particularly those ... Their goal is to find ways to optimize the ... renewable resources for fuel and industrial chemicals. The ...
    ... ,(Phoenix ... awarded Robert Garfield, PhD, a researcher at St. Joseph,s Hospital and Medical ... to prevent post-partum hemorrhage. The grant was one of 88 awarded ... help lower the barriers for testing innovative ideas in global health. Phase ...
    Cached Biology News:Re-inventing America's urban water infrastructure 2Re-inventing America's urban water infrastructure 3Re-inventing America's urban water infrastructure 4Modeling plant metabolism to optimize oil production 2Modeling plant metabolism to optimize oil production 3
    Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
    ... TriEx Sf9 Cells and TriEx Insect ... from pTriEx baculovirus constructs. This cell/medium combination ... cell growth and high protein expression levels ... pTriEx-1.14 vectors. Please note that our Ready-Plaque ...
    ...
    ...
    Biology Products: